发明名称 |
Generation of Endocrine Progenitor Cells from Human Pluripotent Stem Cells Using Small Molecules |
摘要 |
The present invention relates to differentiation of stem cells into a homogeneous endocrine progenitor cell population suitable for further differentiation into pancreatic beta-cells. The present invention provides methods for obtaining NGN3/NKX2.2 double positive endocrine progenitor cells by exposing precursor cells to a TGF-β type I receptor inhibitor, a BMP antagonist, an adenylate cyclase activator and nicotinamide and/or exposing to the precursor cells to a selection of small molecules. |
申请公布号 |
US2016208215(A1) |
申请公布日期 |
2016.07.21 |
申请号 |
US201414913604 |
申请日期 |
2014.08.29 |
申请人 |
NOVO NORDISK A/S ;TAKARA BIO EUROPE AB |
发明人 |
Doehn Ulrik;Christophersen Nicolaj Stroeyer;Ekberg Jenny |
分类号 |
C12N5/071 |
主分类号 |
C12N5/071 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for obtaining endocrine progenitor cells, comprising exposing a cell population comprising pancreatic endoderm cells to a basal medium comprising
a TGF-β type I receptor inhibitor, noggin, an adenylate cyclase activator, and nicotinamide. |
地址 |
Bagsværd DK |